SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYTO -- Ignore unavailable to you. Want to Upgrade?


To: John Mattessich who wrote (7048)3/25/1998 5:34:00 PM
From: John Mattessich  Read Replies (1) | Respond to of 8116
 
To all :
Also check out this press release from SONUS Pharm. Would EchoGen be considered a competitor to Prostascint for diagnosis ?

biz.yahoo.com

John

(BTW, in the last couple of days, in reviewing the latest news on prostate cancer, I've seen a wide range in what is claimed to be the number of men diagnosed with prostate cancer in 1997. Usually, between 200K and 300K. There should be some universally agreed-upon number).